India Glycols Ltd Upgraded to Hold by MarketsMOJO on Improved Valuation and Technicals

Quality Grade Deterioration Amidst Mixed Financial Metrics

India Glycols’ quality grade has been downgraded from average to below average, signalling concerns over its fundamental strength despite some positive growth metrics. Over the past five years, the company has recorded a sales growth rate of 10.31% and an EBIT growth of 18.29%, which are moderate but not exceptional within the commodity chemicals sector. However, its ability to service debt remains weak, with an average EBIT to interest coverage ratio of 2.48 and a relatively high debt to EBITDA ratio of 3.55 times. The net debt to equity ratio stands at 0.60, indicating a moderate leverage position.

Return metrics also reflect challenges; the average return on capital employed (ROCE) is 8.60%, and return on equity (ROE) is 8.69%, both below industry leaders. The company’s sales to capital employed ratio is 0.92, suggesting limited efficiency in asset utilisation. Dividend payout remains low at 13.41%, and institutional holding is modest at 7.47%, with no pledged shares, which is a positive governance indicator. When compared to peers such as Navin Fluorine International and Himadri Speciality Chemicals, which maintain good quality grades, India Glycols’ fundamentals appear weaker, justifying the downgrade in quality.

Valuation Upgraded to Attractive on Improved Metrics

In contrast to the quality downgrade, India Glycols’ valuation grade has improved from fair to attractive. The company currently trades at a price-to-earnings (PE) ratio of 22.67, which is significantly lower than many of its peers in the commodity chemicals sector, such as Navin Fluorine International (PE 54.34) and Himadri Speciality Chemicals (PE 39.09). This relatively modest PE ratio suggests the stock is undervalued compared to its sector counterparts.

Other valuation multiples reinforce this view: the enterprise value to EBITDA ratio stands at 12.77, and the EV to capital employed ratio is a low 1.81. The price-to-book value is 2.27, and the PEG ratio is 1.30, indicating reasonable growth expectations relative to earnings. Dividend yield is modest at 1.22%, but the latest ROCE and ROE have improved to 10.80% and 10.00%, respectively, signalling better capital efficiency in the recent period. These valuation improvements reflect the market’s recognition of India Glycols’ positive financial performance in the latest quarters, despite its longer-term fundamental challenges.

Financial Trend: Positive Quarterly Performance Amidst Long-Term Challenges

India Glycols has demonstrated encouraging financial trends in the near term, with positive results reported for five consecutive quarters, including Q4 FY25-26. The company’s half-year ROCE peaked at 11.79%, and operating profit to interest coverage reached a robust 6.30 times, indicating improved operational efficiency and debt servicing capability. The debt-equity ratio has also declined to a low 0.58 times, reflecting a stronger balance sheet.

Despite these short-term improvements, the company’s long-term fundamentals remain under pressure. Over the past five years, net sales have grown at a modest annual rate of 10.31%, and operating profit has increased by 18.29%. While these figures are positive, they lag behind the more dynamic growth rates seen in some peers. Additionally, the company’s ability to service debt is constrained by a relatively high debt to EBITDA ratio of 2.60 times, which could limit financial flexibility.

From a shareholder perspective, domestic mutual funds hold a mere 0.51% stake in India Glycols, suggesting limited institutional conviction. Given that mutual funds typically conduct thorough research, this low holding may indicate concerns about valuation or business prospects at current levels.

Technical Indicators Shift to Bullish, Supporting the Upgrade

The technical grade for India Glycols has been upgraded from mildly bullish to bullish, reflecting stronger momentum in the stock’s price action. Key technical indicators present a mixed but generally positive picture. On a weekly basis, the MACD is bullish, while the monthly MACD remains mildly bearish. The Relative Strength Index (RSI) shows no clear signal on either timeframe, but Bollinger Bands indicate mild bullishness both weekly and monthly.

Moving averages on the daily chart are bullish, and the Know Sure Thing (KST) indicator is bullish weekly, though mildly bearish monthly. Dow Theory signals are mildly bearish weekly but mildly bullish monthly, while On-Balance Volume (OBV) is mildly bullish weekly and bullish monthly. These mixed signals suggest a strengthening trend with some caution, but overall the technical outlook supports the recent upgrade to a Hold rating.

Price action has been relatively stable, with the current price at ₹993.45, slightly down from the previous close of ₹998.50. The stock’s 52-week high is ₹1,222.85, and the low is ₹793.95, indicating a wide trading range. Over the past year, India Glycols has delivered a 14.89% return, outperforming the Sensex, which declined by 7.23% in the same period. Longer-term returns are even more impressive, with a 5-year return of 304.87% compared to Sensex’s 51.96%, underscoring the company’s market-beating performance over time.

Balancing Strengths and Weaknesses: What Investors Should Consider

India Glycols’ upgrade to Hold reflects a balanced assessment of its current position. The company’s attractive valuation and improving technical indicators provide a compelling case for investors to maintain exposure. Its recent positive quarterly financial performance, including a strong ROCE of 10.8% and improved interest coverage, further supports this stance.

However, the downgrade in quality grade to below average highlights persistent concerns about long-term growth and financial health. The company’s moderate sales and EBIT growth rates, coupled with a relatively high debt burden and limited institutional interest, suggest caution. Investors should weigh these factors carefully, considering the stock’s market-beating returns over the medium to long term against the risks posed by weaker fundamentals.

Overall, India Glycols remains a small-cap player in the commodity chemicals sector with a mixed outlook. The Hold rating and Mojo Score of 57.0 reflect this nuanced view, signalling neither a strong buy nor a sell recommendation but rather a call for measured participation based on individual risk tolerance and portfolio strategy.

Conclusion

The recent upgrade of India Glycols Ltd from Sell to Hold is underpinned by a complex set of factors. While the company’s quality grade has declined due to below-average financial metrics and growth prospects, valuation improvements and bullish technical trends have enhanced its investment appeal. Positive quarterly results and market-beating returns over the past year and beyond provide further support for the Hold rating. Investors should remain vigilant about the company’s long-term fundamentals and debt levels but can consider maintaining a position given the current attractive valuation and improving technical momentum.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today